Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells

Elena Binda(Casa Sollievo della Sofferenza), Alberto Visioli(Biogen (Italy)), Fabrizio Giani(University of Milano-Bicocca), Nadia Trivieri(Casa Sollievo della Sofferenza), Orazio Palumbo(Casa Sollievo della Sofferenza), Silvia Restelli(Biogen (Italy)), Fabio Dezi(Casa Sollievo della Sofferenza), Tommaso Mazza(Casa Sollievo della Sofferenza), Caterina Fusilli(Casa Sollievo della Sofferenza), Federico Legnani(The Neurological Institute), Massimo Carella(Casa Sollievo della Sofferenza), Francesco Di Meco(Johns Hopkins University), Rohit Duggal(Sorrento Therapeutics (United States)), Angelo L. Vescovi(Casa Sollievo della Sofferenza)
Cancer Research
December 23, 2016
Cited by 100Open Access
Full Text

Abstract

Abstract Brain invasion by glioblastoma determines prognosis, recurrence, and lethality in patients, but no master factor coordinating the invasive properties of glioblastoma has been identified. Here we report evidence favoring such a role for the noncanonical WNT family member Wnt5a. We found the most invasive gliomas to be characterized by Wnt5a overexpression, which correlated with poor prognosis and also discriminated infiltrating mesenchymal glioblastoma from poorly motile proneural and classical glioblastoma. Indeed, Wnt5a overexpression associated with tumor-promoting stem-like characteristics (TPC) in defining the character of highly infiltrating mesenchymal glioblastoma cells (Wnt5aHigh). Inhibiting Wnt5a in mesenchymal glioblastoma TPC suppressed their infiltrating capability. Conversely, enforcing high levels of Wnt5a activated an infiltrative, mesenchymal-like program in classical glioblastoma TPC and Wnt5aLow mesenchymal TPC. In intracranial mouse xenograft models of glioblastoma, inhibiting Wnt5a activity blocked brain invasion and increased host survival. Overall, our results highlight Wnt5a as a master regulator of brain invasion, specifically TPC, and they provide a therapeutic rationale to target it in patients with glioblastoma. Cancer Res; 77(4); 996–1007. ©2016 AACR.


Related Papers

No related papers found

Powered by citation graph analysis